Bausch Health Companies Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Bausch Health Companies Inc.
- Former names
- Valeant Pharmaceuticals International, Inc. BIOVAIL Corp Biovail Corp International Biovail Corporation International
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- New Jersey
- Headquarters city
- Quebec
- Headquarters country
- Canada
- Fiscal year end
- December
- Ticker symbol
- BHC
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000885590
Board of directors
-
Amy B. Wechsler · DirectorSince 2023
- Since 2023
-
Christian A. Garcia · DirectorSince 2024
-
Eiry Roberts · DirectorSince 2026
-
Frank D. Lee · DirectorSince 2024
-
John Paulson · DirectorSince 2023
-
Michael Goettler · DirectorSince 2025
-
Richard Mulligan · DirectorSince 2023
-
Robert N. Power · DirectorSince 2023
-
Russel C. Robertson · DirectorSince 2023
-
Sandra Leung · DirectorSince 2025
-
Sarah B. Kavanagh · DirectorSince 2023
-
Schutter Richard U. De · DirectorSince 2023
- Since 2023
-
Thomas Appio · Director · Chief Executive OfficerSince 2023
-
Thomas W. Ross Sr. · DirectorSince 2023
Chief executives
Thomas Appio
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.2%
-
93.3%
-
94.4%
-
98.1%
-
98.2%
-
98.3%
-
98.6%
-
98.6%
-
98.6%
-
98.7%
Board connections
13 of this board's directors also sit on 18 other boards.
- via Brett Icahn, John Paulson, Russel C. Robertson, Sarah B. Kavanagh, Schutter Richard U. De, Thomas Appio and Thomas W. Ross Sr.
- via Brett Icahn, Christian A. Garcia and Steven D. Miller
- via Brett Icahn and Richard Mulligan
- via John Paulson
- via Frank D. Lee
- via Brett Icahn
- via Steven D. Miller
- via Amy B. Wechsler
- via Brett Icahn
- via Steven D. Miller
- via Christian A. Garcia
- via Brett Icahn
- via Frank D. Lee
- via Richard Mulligan
- via Brett Icahn
- via Christian A. Garcia
- via Michael Goettler
- via Steven D. Miller
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $15,625,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $506,730
- 5 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Lenar Aimee J. Officer (President, US Pharma) | Open-market sale | −36,827 | $7.03 | $258,894 |
| Jul 17, 2026 | Lenar Aimee J. Officer (President, US Pharma) | Shares withheld for tax | −5,260 | $4.83 | $25,406 |
| Jul 15, 2026 | Lenar Aimee J. Officer (President, US Pharma) | Shares withheld for tax | −23,395 | $4.89 | $114,402 |
| Jul 14, 2026 | LEE STEVEN HYOSIG Officer (SVP, Controller & CAO) | Shares withheld for tax | −3,125 | $4.75 | $14,844 |
| Jun 30, 2026 | Sandra Leung Director | Grant or award | +6,845 | $4.93 | $33,746 |
| Jun 30, 2026 | John Paulson Director | Grant or award | +12,677 | $4.93 | $62,498 |
| Jun 30, 2026 | Amy B. Wechsler Director | Grant or award | +1,394 | $4.93 | $6,872 |
| May 22, 2026 | Amy B. Wechsler Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | Eiry Roberts Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | Robert N. Power Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | John Paulson Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | Sandra Leung Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | Frank D. Lee Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | Sarah B. Kavanagh Director | Grant or award | +45,871 | — | — |
| May 22, 2026 | Michael Goettler Director | Grant or award | +45,871 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.